Galectin-9 (Gal-9), the first ligand identified for TIM-3, eliminates interferon γ-producing Th1 cells, thereby reducing the severity and mortality of experimental autoimmune encephalomyelitis (60) (Table 2). The gene discussed is LGALS9; the disease is experimental autoimmune encephalomyelitis.